Browsing by Author "Russell, Rachel"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Effect of Virtual Reality Interventions on Occupational Participation in Stroke Patients: A Rapid Systematic Review
    (2023-05-04) Gillen, Grace; Huff, Nichole; Messenger, Elizabeth; Russell, Rachel; Butcher, Madison; Chase, Tony; Sego, Daniel; Department of Occupational Therapy, School of Health and Human Sciences
    This rapid systematic review of the literature examines the literature on effective occupational therapy virtual reality (VR) interventions in rehabilitation of individuals poststroke. This review provides a comprehensive overview and analysis of 25 studies that addressed common themes, including: upper extremity (UE) mobility, functional outcomes, Quality of Life (QoL), and functional performance, related to increasing occupational participation through VR. Findings reveal moderate strength of evidence for the use of VR interventions, in addition to conventional occupational therapy (OT), in supporting individuals’ occupational performance and relative, functional factors contributing to participation in occupations, among individuals following a stroke. This review supports the use of VR interventions for individuals poststroke due to their innovativeness, adaptability, and ability to simulate real-life activities of daily living (ADLs), and supports the use of occupation-based VR interventions which can inform and guide intervention approaches for OT practitioners working in stroke rehabilitation.
  • Thumbnail Image
    Item
    The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
    (Oxford University Press, 2022-09-12) Hayes, Hailey; Russell, Rachel; Haugen, Amber; Nagavally, Sneha; Sarvaideo, Jenna; Pediatrics, School of Medicine
    Context: Current Endocrine Society guidelines recommend that transgender women taking spironolactone have their potassium levels checked every 3 months for the first year after initiating therapy and annually thereafter to monitor for hyperkalemia. Objective: The goal of this study was to assess the need for such frequent potassium monitoring and to investigate whether age plays a role in potassium abnormalities in transgender, gender diverse, and nonbinary (TGDNB) individuals taking spironolactone. Methods: Using EPIC-Clarity, a retrospective study of healthy, adult individuals with gender-identity disorder listed in their problem list and taking spironolactone was performed. We analyzed the incidence of hyperkalemia in this population. Data from June 2006 through November 2021 were obtained. Exclusion criteria included hypertension, renal failure, diabetes mellitus, heart failure, and medications that affect the renin-angiotensin-aldosterone system. Results: 318 healthy TGDNB individuals met our inclusion criteria. We identified 8/318 (2.5%) individuals with hyperkalemia on spironolactone. There was a significant difference in incidence of hyperkalemia events in those >45 years old and those ≤45 years old (8.9% vs 1.5%, P = .016). Conclusion: Our data suggest the incidence of hyperkalemia in our TGDNB population is low, particularly in those ≤45 years old; however, this risk increases with age. These findings suggest practice guidelines may need to be adjusted to minimize unnecessary testing in the population ≤45 years old who are not plagued by comorbidities that affect potassium handling.